| Authors: |
Niemann CU; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: carsten.utoft.niemann@regionh.dk., Munir T; St James's Hospital, Leeds, UK., Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Owen C; Tom Baker Cancer Centre, Calgary, AB, Canada., Follows GA; Addenbrookes Hospital, Cambridge, UK., Benjamini O; Sheba Medical Center, Ramat Gan, Israel., Janssens A; UZ Leuven Gasthuisberg, Leuven, Belgium., Levin MD; Albert Schweitzer Hospital, Dordrecht, Netherlands., Robak T; Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Simkovic M; 4th Department of Internal Medicine-Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Králové, Czech Republic., Voloshin S; Russian Scientific and Research Institute of Hematology and Transfusiology, St Petersburg, Russia., Vorobyev V; SP Botkin Moscow City Clinical Hospital, Moscow, Russia., Yagci M; Gazi Universitesi Tip Fakultesi, Ankara, Türkiye., Ysebaert L; Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Qi K; Janssen Research & Development, Titusville, NJ, USA., Qi Q; Janssen Research & Development, Raritan, NJ, USA., Sinet P; Janssen Research & Development, Bridgewater, NJ, USA., Parisi L; Janssen Research & Development, Raritan, NJ, USA., Srinivasan S; Oncology Translational Research, Janssen Research & Development, Lower Gwynedd Township, PA, USA., Schuier N; Janssen Research & Development, Raritan, NJ, USA., Baeten K; Janssen Research & Development, Beerse, Belgium., Howes A; Janssen Research & Development, High Wycombe, UK., Caces DB; Janssen Research & Development, Raritan, NJ, USA., Kater AP; Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, Netherlands. |
